S3852 Dna analysis apoe alzheimer
Also known as: APOE gene test, Alzheimer genetic risk
Deoxyribonucleic acid analysis of Apolipoprotein E genotype for assessment of Alzheimer disease risk in patients with cognitive decline.
In Plain Language
genetic test for Alzheimer risk; Alzheimer's disease gene screening
Clinical Context
Used in neurology for assessment of genetic risk factors in patients with mild cognitive impairment or Alzheimer disease.
RVU Information
CPT S3852 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
S-codes are used by private payers (not Medicare) for services without a standard CPT or HCPCS code. Coverage varies significantly between insurers. Verify payer acceptance before billing and document medical necessity thoroughly.
Specialties
Frequently Asked Questions
What is CPT code S3852?
CPT S3852 (Dna analysis apoe alzheimer) is a S Codes code. Deoxyribonucleic acid analysis of Apolipoprotein E genotype for assessment of Alzheimer disease risk in patients with cognitive decline.
Is S3852 covered by insurance?
S3852 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used in neurology for assessment of genetic risk factors in patients with mild cognitive impairment or Alzheimer disease.
When is CPT S3852 used?
Used in neurology for assessment of genetic risk factors in patients with mild cognitive impairment or Alzheimer disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.